These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Relationship of Tumor Radiation-absorbed Dose to Survival and Response in Hepatocellular Carcinoma Treated with Transarterial Radioembolization with Hermann AL; Dieudonné A; Ronot M; Sanchez M; Pereira H; Chatellier G; Garin E; Castera L; Lebtahi R; Vilgrain V; Radiology; 2020 Sep; 296(3):673-684. PubMed ID: 32602828 [TBL] [Abstract][Full Text] [Related]
7. Post-radioembolization yttrium-90 PET/CT - part 2: dose-response and tumor predictive dosimetry for resin microspheres. Kao YH; Steinberg JD; Tay YS; Lim GK; Yan J; Townsend DW; Budgeon CA; Boucek JA; Francis RJ; Cheo TS; Burgmans MC; Irani FG; Lo RH; Tay KH; Tan BS; Chow PKh; Satchithanantham S; Tan AE; Ng DC; Goh AS EJNMMI Res; 2013 Jul; 3(1):57. PubMed ID: 23885971 [TBL] [Abstract][Full Text] [Related]
8. Radioembolization of hepatocarcinoma with Chiesa C; Mira M; Bhoori S; Bormolini G; Maccauro M; Spreafico C; Cascella T; Cavallo A; De Nile MC; Mazzaglia S; Capozza A; Tagliabue G; Brusa A; Marchianò A; Seregni E; Mazzaferro V Eur J Nucl Med Mol Imaging; 2020 Dec; 47(13):3018-3032. PubMed ID: 32451604 [TBL] [Abstract][Full Text] [Related]
9. Voxel-Based Dosimetry Predicts Hepatotoxicity in Hepatocellular Carcinoma Patients Undergoing Radioembolization with Watanabe M; Grafe H; Theysohn J; Schaarschmidt B; Ludwig J; Jochheim L; Jeschke M; Schmidt H; Fendler WP; Moraitis A; Herrmann K; Pomykala KL; Weber M J Nucl Med; 2023 Jul; 64(7):1102-1108. PubMed ID: 37290792 [TBL] [Abstract][Full Text] [Related]
10. High quality imaging and dosimetry for yttrium-90 ( Duan H; Khalaf MH; Ferri V; Baratto L; Srinivas SM; Sze DY; Iagaru A Eur J Nucl Med Mol Imaging; 2021 Jul; 48(8):2426-2436. PubMed ID: 33443618 [TBL] [Abstract][Full Text] [Related]
11. Voxel-based dosimetry predicting treatment response and related toxicity in HCC patients treated with resin-based Y90 radioembolization: a prospective, single-arm study. Kokabi N; Arndt-Webster L; Chen B; Brandon D; Sethi I; Davarpanahfakhr A; Galt J; Elsayed M; Bercu Z; Cristescu M; Kappadath SC; Schuster DM Eur J Nucl Med Mol Imaging; 2023 May; 50(6):1743-1752. PubMed ID: 36650357 [TBL] [Abstract][Full Text] [Related]
12. Analysis of dynamic hepatobiliary contrast-enhanced MRI signal intensity after Yttrium-90 radioembolization with glass microspheres for the treatment of hepatocellular carcinoma. Syed M; Shah J; Montazeri SA; Grajo JR; Geller B; Toskich B Abdom Radiol (NY); 2021 May; 46(5):2182-2187. PubMed ID: 33216180 [TBL] [Abstract][Full Text] [Related]
13. Image-guided personalized predictive dosimetry by artery-specific SPECT/CT partition modeling for safe and effective 90Y radioembolization. Kao YH; Hock Tan AE; Burgmans MC; Irani FG; Khoo LS; Gong Lo RH; Tay KH; Tan BS; Hoe Chow PK; Eng Ng DC; Whatt Goh AS J Nucl Med; 2012 Apr; 53(4):559-66. PubMed ID: 22343503 [TBL] [Abstract][Full Text] [Related]
14. Tumor Targeting and Three-Dimensional Voxel-Based Dosimetry to Predict Tumor Response, Toxicity, and Survival after Yttrium-90 Resin Microsphere Radioembolization in Hepatocellular Carcinoma. Allimant C; Kafrouni M; Delicque J; Ilonca D; Cassinotto C; Assenat E; Ursic-Bedoya J; Pageaux GP; Mariano-Goulart D; Aho S; Guiu B J Vasc Interv Radiol; 2018 Dec; 29(12):1662-1670.e4. PubMed ID: 30217745 [TBL] [Abstract][Full Text] [Related]
15. Impact of SPECT corrections on 3D-dosimetry for liver transarterial radioembolization using the patient relative calibration methodology. Pacilio M; Ferrari M; Chiesa C; Lorenzon L; Mira M; Botta F; Becci D; Torres LA; Coca Perez M; Vergara Gil A; Basile C; Ljungberg M; Pani R; Cremonesi M Med Phys; 2016 Jul; 43(7):4053. PubMed ID: 27370124 [TBL] [Abstract][Full Text] [Related]
16. Radioembolization of hepatocarcinoma with (90)Y glass microspheres: development of an individualized treatment planning strategy based on dosimetry and radiobiology. Chiesa C; Mira M; Maccauro M; Spreafico C; Romito R; Morosi C; Camerini T; Carrara M; Pellizzari S; Negri A; Aliberti G; Sposito C; Bhoori S; Facciorusso A; Civelli E; Lanocita R; Padovano B; Migliorisi M; De Nile MC; Seregni E; Marchianò A; Crippa F; Mazzaferro V Eur J Nucl Med Mol Imaging; 2015 Oct; 42(11):1718-1738. PubMed ID: 26112387 [TBL] [Abstract][Full Text] [Related]
17. Post-treatment three-dimensional voxel-based dosimetry after Yttrium-90 resin microsphere radioembolization in HCC. Veenstra EB; Ruiter SJS; de Haas RJ; Bokkers RPH; de Jong KP; Noordzij W EJNMMI Res; 2022 Feb; 12(1):9. PubMed ID: 35122166 [TBL] [Abstract][Full Text] [Related]
18. Clinical Results of Holmium-166 Radioembolization with Personalized Dosimetry for the Treatment of Hepatocellular Carcinoma. Kühnel C; Köhler A; Brachwitz T; Seifert P; Gühne F; Aschenbach R; Freudenberg R; Freesmeyer M; Drescher R J Pers Med; 2024 Jul; 14(7):. PubMed ID: 39064001 [TBL] [Abstract][Full Text] [Related]
19. Intrahepatic cholangiocarcinoma: a dose threshold evaluation in those undergoing transarterial radioembolization. Young S; Torkian P; Flanagan S; D'Souza D; Sanghvi T; Golzarian J J Gastrointest Oncol; 2023 Oct; 14(5):2202-2211. PubMed ID: 37969824 [TBL] [Abstract][Full Text] [Related]
20. Planning dosimetry for Thomas MA; Mahvash A; Abdelsalam M; Kaseb AO; Kappadath SC Med Phys; 2020 Oct; 47(10):5333-5342. PubMed ID: 32790882 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]